RxDoctor Payments Data

Richard Rosa, MD

Orthopaedic Surgery · West Orange, NJNPI 1396739694

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $54,294 of the $72,758 with a category attached, or 74.6%. Conformis, Inc. accounts for 78.5% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $65,392 and has fallen 99.8% since, to $157 in 2025. Among orthopaedic surgery clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$72,758in general payments, 2019–2025

Across 57 payments — averaging $1276.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Conformis, Inc.$57K
  • Stryker$12K
  • Restor3d, Inc.$3K
  • Ferring Pharmaceuticals Inc.$174
  • Orthosensor Inc.$58
  • Medline Industries LP$31
  • plus $44 from 2 others

What the payments were for

  • Consulting fees$13,53219%
  • Speaking & faculty fees$54,29475%
  • Travel & lodging$3,6255%
  • Food & beverage$1,3082%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Conformis, Inc.24$57,112
Stryker3$12,400
Restor3d, Inc.16$2,939
Ferring Pharmaceuticals Inc.9$174
Orthosensor Inc.1$58
Medline Industries LP1$31
Smith+Nephew2$30
Bioventus LLC1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$72,758 in reported general payments places this provider in the 90th percentile of 587 orthopaedic surgery providers in New Jersey.

See all orthopaedic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$690,514
Medicare patients
859
Services billed
24,033

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib35$401

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in West Orange

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →